S. M. O'Donovan

Latest

• Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study
• Schizophrenia: a disorder of broken brain bioenergetics
• The active kinome: The modern view of how active protein kinase networks fit in biological research
• Editorial overview: Neuroscience: Advances in the field
• Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
• Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
• Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
• Role of Astrocytes in Major Neuropsychiatric Disorders
• KEOPS complex expression in the frontal cortex in major depression and schizophrenia
• KEOPS complex expression in the frontal cortex in major depression and schizophrenia
• Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach
• Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
• Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter
• Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia
• A bioinformatic inquiry of the EAAT2 interactome in postmortem and neuropsychiatric datasets
• Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia
• Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
• Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
• Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia
• Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
• Cell-subtype-specific changes in adenosine pathways in schizophrenia
• Defects in Bioenergetic Coupling in Schizophrenia
• The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
• Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression
• Shaping plasticity: Alterations in glutamate transporter localization as a pathophysiological mechanism in severe mental illness
• Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?
• Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia